CONMED Corporation

CONMED Corporation

CNMDยทNYSE

$33.06

-2.3%
HealthcareMedical - Devices

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

At a Glance

Live Snapshot
Market Cap$995.41M
EPS1.5200
P/E Ratio21.75
Earnings Date07/29/2026
CONMED Corporation

CONMED Corporation Fair Value Envelope

CNMD ยท NYSE

Our analysis suggests that CNMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $33.06, this represents a potential HIDDEN relative to our calculated worth for CONMED Corporation.

Intrinsic Value
Current Price: $33.06

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$2.1B
+ Cash & Equivalents$40.8M
Firm Value$2.1B
- Debt$834.9M
Equity Value$1.3B
/ Shares Outstanding30,967,954B
DCF Value$42
UNDERVALUED BY 27%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$167.4M
$164.1M
$160.9M
$157.8M
$154.7M
$151.7M
$148.7M
$145.8M
$143.0M
$140.2M
Maintenance CapEx
-$3.9M
-$3.8M
-$3.7M
-$3.7M
-$3.6M
-$3.5M
-$3.5M
-$3.4M
-$3.3M
-$3.3M
Owner Earnings
$163.5M
$160.3M
$157.2M
$154.1M
$151.1M
$148.1M
$145.3M
$142.4M
$139.6M
$136.9M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$151.4M
$137.4M
$124.8M
$113.3M
$102.8M
$93.4M
$84.8M
$76.9M
$69.9M
$63.4M
Terminal Value represents 51.4% of Enterprise Value